James Jones

Affiliations reported with papers

Linked publications

A Single-Agent Dual-Specificity Targeting of FOLR1 and DR5 as an Effective Strategy for Ovarian Cancer 2018

Related research

FOLR1-anchored DR5 bispecific antibody